Solana (NASDAQ:HSDT) held its 2026 annual stockholders meeting virtually on May 21, with shareholders approving all three proposals presented by the company’s board.
Joseph Chee, Solana’s chairman, chief executive officer and president, called the meeting to order at 9:00 a.m. Eastern Time and said the virtual meeting was being hosted through Broadridge. Chee introduced participating board members Cosmo Jiang and Blane Walter, as well as company officers including Agustina “Madelene” Gani, identified during the meeting as chief financial officer and chief operating officer. Matthew Weller of CBIZ CPAs, P.C., the company’s independent registered public accounting firm, also attended virtually.
Shareholders Elect Directors
Stockholders voted on three proposals during the meeting. The first proposal was the election of four directors to serve until the next annual meeting and until their successors are elected. The nominees were Joseph Chee, Blane Walter, Edward M. Straw and Cosmo Jiang.
According to the preliminary voting report delivered by Gani, all four nominees were elected as directors of the company.
Auditor Appointment Ratified
The second proposal was the ratification of the appointment of CBIZ CPAs, P.C. as Solana’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
Gani reported that shareholders ratified the appointment. No questions were submitted for the auditors during the meeting, according to the company.
Two Additional Directors Approved
The third proposal was the election of two additional directors to serve until the next annual meeting and until their successors are elected. The nominees were Michel Lee and Sergio Mello.
Gani said the preliminary report from the inspector of election showed that both Lee and Mello were elected as directors.
No Stockholder Questions Submitted
Chee said shareholders attending with a valid 16-digit control number could submit questions or comments through the virtual meeting platform, with the company limiting the question-and-answer portion to matters related to the proposals or the meeting. After the proposals were presented, Gani reported that no questions had been submitted.
After the polls closed, the company announced that it expects to report preliminary voting results, or final voting results if available on a timely basis, in a current report on Form 8-K to be filed with the Securities and Exchange Commission within four business days after the meeting. If final results are not reported at that time, Solana said it expects to file an amendment to its Form 8-K within four business days after the final results are known.
Chee concluded the meeting by thanking shareholders for their attendance and continued support of the company.
About Solana (NASDAQ:HSDT)
Helius Medical Technologies, Inc (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non?invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions.
The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics.
